Your provider should assess baseline GI symptoms, establish a slower titration schedule, and monitor for new or worsening bloating, diarrhea, or abdominal pain at each dose increase
Knowing that profile before committing to a long-term protocol is the test before you invest approach turning guesswork into a more informed conversation with your healthcare provider
14, GOVINDPURI EXTENSION, New Delhi, Delhi, 110019, India Report incorrect details
Back Phelan, M (30 May 2024) 'Winning researchers unlocked GLP-1 drugs for obesity', Science , 384/6699
The speed of weight loss on semaglutide depends heavily on starting weight, diet adherence, physical activity, and individual metabolic factors
Fat mass reduction The body composition substudy measured total fat mass changes using dual-energy X-ray absorptiometry, the gold standard for distinguishing fat from lean tissue